Arkolith/Insider Trading/HALO/Form 4

Connaughton Bernadette

DirectorHALOZYME THERAPEUTICS, INC. (HALO) · full profile →Form 4 · filed Jul 2, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$125K
Net Open-Market Flow
-$125K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 1, 2026Sell(S)1K$76.39$76K43K
Jul 1, 2026Sell(S)625$77.21$48K42K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001159036-26-000094) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML